摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氨基-6-氯苯并噁唑 | 52112-68-2

中文名称
2-氨基-6-氯苯并噁唑
中文别名
2-氨基-6-氯苯并恶唑
英文名称
6-chlorobenzo[d]oxazol-2-amine
英文别名
2-amino-6-chlorobenzoxazole;6-chloro-1,3-benzoxazol-2-amine
2-氨基-6-氯苯并噁唑化学式
CAS
52112-68-2
化学式
C7H5ClN2O
mdl
MFCD01664218
分子量
168.583
InChiKey
QDMXVLGVKMTTIT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    184 °C
  • 沸点:
    316.8±34.0 °C(Predicted)
  • 密度:
    1.4369 (rough estimate)

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    52
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 危险等级:
    IRRITANT
  • 海关编码:
    2934999090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    库房应保持通风、低温和干燥的环境。

SDS

SDS:aed54e2e3588637ff2b025715bc1c332
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Amino-6-chlorobenzoxazole
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Amino-6-chlorobenzoxazole
CAS number: 52112-68-2

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H5ClN2O
Molecular weight: 168.6

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

类别:有毒物品

毒性分级:高毒

急性毒性:

  • 口服 - 大鼠 LD50:226 毫克/公斤
  • 口服 - 小鼠 LD50:600 毫克/公斤

可燃性危险特性:可燃;燃烧时产生有毒氮氧化物和氯化物烟雾

储运特性:库房需通风、低温且干燥

灭火剂:干粉、泡沫、砂土、二氧化碳或雾状水

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-氨基-6-氯苯并噁唑三乙胺 作用下, 以 二氯甲烷N,N-二甲基甲酰胺 为溶剂, 生成 1-(3-chloro-4-hydroxyphenyl)-3-(6-chlorobenzo[d]oxazol-2-yl)urea
    参考文献:
    名称:
    苯并噻唑尿素是17β-HSD10的低微摩尔和非竞争性抑制剂,与阿尔茨海默氏病的治疗有关
    摘要:
    人17β-羟类固醇脱氢酶10型是一种多功能蛋白,参与线粒体内的许多酶和结构过程。该酶被认为与几种神经系统疾病有关,例如智力低下,帕金森氏病或阿尔茨海默氏病,其中该酶与淀粉样β肽相互作用。我们基于苯并噻唑基支架制备了约60种新化合物,并评估了它们的抑制能力和作用机理。最有效的抑制剂在苯环部分包含3-氯和4-羟基取代基,在苯并噻唑部分的6位上具有小的取代基,并且两个部分通过脲连接基连接(4at,4bb和4bg)。这些化合物的IC50值为1-2μM,对底物乙酰乙酰辅酶A表现出无竞争性的作用机理。这些17β-羟基类固醇脱氢酶的非竞争性苯并噻唑基抑制剂是有希望用于神经退行性疾病潜在药物的化合物,值得进一步研究和开发。
    DOI:
    10.3390/ijms21062059
  • 作为产物:
    描述:
    2-氨基苯并噁唑 作用下, 以 氯仿 为溶剂, 生成 2-氨基-6-氯苯并噁唑
    参考文献:
    名称:
    苯甲唑类:强效骨骼肌放松剂。
    摘要:
    DOI:
    10.1002/jps.2600530518
点击查看最新优质反应信息

文献信息

  • [EN] TETRAHYDROBENZOFURO[2,3-C]PYRIDINE AND BETA-CARBOLINE COMPOUNDS FOR THE TREATMENT, ALLEVIATION OR PREVENTION OF DISORDERS ASSOCIATED WITH TAU AGGREGATES<br/>[FR] COMPOSÉS DE TÉTRAHYDROBENZOFURO[2,3-C]PYRIDINE ET DE BÊTA-CARBOLINE POUR LE TRAITEMENT, LE SOULAGEMENT OU LA PRÉVENTION DE TROUBLES ASSOCIÉS À DES AGRÉGATS DE PROTÉINE TAU
    申请人:AC IMMUNE SA
    公开号:WO2019233883A1
    公开(公告)日:2019-12-12
    The present invention relates to novel compounds of formula (I) that can be employed in the treatment, alleviation or prevention of a group of disorders and abnormalities associated with Tau (Tubulin associated unit) protein aggregates including, but not limited to, Neurofibrillary Tangles (NFTs), such as Alzheimer's disease (AD).
    本发明涉及一种可以用于治疗、缓解或预防与Tau(微管相关单元)蛋白聚集相关的一组疾病和异常的新化合物(I)的公式。这些疾病和异常包括但不限于神经原纤维缠结(NFTs),如阿尔茨海默病(AD)。
  • Design, synthesis, and evaluation of substituted 2-acylamide-1,3-benzo[d]zole analogues as agents against MDR- and XDR-MTB
    作者:Dongsheng Li、Chao Liu、Xinhai Jiang、Yuan Lin、Jing Zhang、Yan Li、Xuefu You、Wei Jiang、Minghua Chen、Yanni Xu、Shuyi Si
    DOI:10.1016/j.ejmech.2020.112898
    日期:2021.1
    concentration (MIC) of 0.42 μM. In this study, a series of substituted 2-acylamide-1,3-zole analogues were designed and synthesized, and their anti-Mtb activities were analyzed. In total, 17 compounds were found to be potent anti-Mtb agents, especially against the MDR- and XDR-MTB strains, with MIC values < 10 μM. These analogues can inhibit both drug-sensitive and drug-resistant Mtb. Four representative compounds
    N-(5-氯苯并[d]恶唑-2-基)-4-甲基-1,2,3-噻二唑-5-羧酰胺氧酰胺已被确认为是Mtb H37Rv的有效抑制剂,其最低抑制浓度为( MIC)为0.42μM。在这项研究中,设计和合成了一系列取代的2-酰基酰胺-1,3-唑类似物,并分析了它们的抗Mtb活性。总共发现17种化合物是有效的抗Mtb剂,特别是针对MDR-和XDR-MTB菌株,MIC值<10μM。这些类似物可以抑制药物敏感性和耐药性Mtb。选择了四种代表性化合物进行进一步分析,结果表明化合物18具有可接受的安全性,并具有良好的药代动力学(PK)特性。此外,该化合物对革兰氏阳性菌显示出强效活性,MIC值为1.48–11.86μM。本文获得的数据表明,可以通过结构修饰开发有希望的抗Mtb候选药物,并且需要进一步的研究来探索其他化合物。
  • Amido Compounds
    申请人:Brotherton-Pleiss Christine E.
    公开号:US20120149718A1
    公开(公告)日:2012-06-14
    Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein the variables are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with the P2X7 purinergic receptor.
    化合物的公式I:或其药用盐,其中变量的定义如本文所述。还公开了制备这些化合物的方法,并将这些化合物用于治疗与P2X7嘌呤受体相关的疾病。
  • 取代的苯并-1,3-杂唑类化合物、其制备方法 及用途
    申请人:中国医学科学院医药生物技术研究所
    公开号:CN103772376B
    公开(公告)日:2017-01-11
    本发明涉及通式Ⅰ所示的取代的苯并‑1,3‑杂唑类化合物,本发明还涉及所述化合物的制备方法及其用于制备抗结核药物的用途。本发明的化合物不仅对结核杆菌敏感株有效,而且还对对异烟肼和利福平等传统一线抗结核药物均有耐药性的耐药菌株有效,是很有应用前景的新型抗结核杆菌化合物。
  • Synthesis of Cyanamides via a One-Pot Oxidation–Cyanation of Primary and Secondary Amines
    作者:Nadine Kuhl、Saurin Raval、Ryan D. Cohen
    DOI:10.1021/acs.orglett.8b04007
    日期:2019.3.1
    operationally simple oxidation–cyanation method for the synthesis of cyanamides is described. The procedure utilizes inexpensive and commercially available N-chlorosuccinimide and Zn(CN)2 as reagents to avoid direct handling of toxic cyanogen halides. It is demonstrated to be amenable for the cyanation of a variety of primary and secondary amines and aniline derivatives as well as a complex synthetic
    描述了一种用于操作合成氰胺的简单操作的氧化氰化方法。该方法利用廉价的和可商购的N-氯代琥珀酰亚胺和Zn(CN)2作为试剂,以避免直接处理有毒的氰化卤化物。事实证明,它适用于各种伯胺和仲胺和苯胺衍生物的氰化,以及在向verubecestat(MK-8931)途中的复杂合成中间体。另外,据报道动力学测量和其他对照实验揭示了该氰化反应的机理。
查看更多

同类化合物

(N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) 钙离子载体A23187半镁盐 荧光增白剂EBF 苯并恶唑胺 苯并恶唑的取代物 苯并恶唑甲磺酰氯 苯并恶唑基-2-甲酰基-S-乙基-异缩氨基硫脲 苯并恶唑-2-羧酸酰肼 苯并恶唑-2-磺酸 苯并恶唑-2-甲酸 苯并恶唑-2-甲磺酸钠 苯并恶唑-2-乙酸 苯并恶唑 苯并噁唑-5-甲酸 苯并噁唑-2-羧酸乙酯 苯并噁唑-2-甲醛 苯并噁唑,4,7-二氯-2-(氯甲基)- 苯并噁唑,2-叠氮- 苯并噁唑,2-(氯甲基)-4,7-二氟- 苯并[d]恶唑-7-甲酸甲酯 苯并[d]恶唑-5-硼酸频哪醇酯 苯并[d]噁唑-6-甲醛 苯并[d]噁唑-2-羧酸甲酯 苯并[d]噁唑-2-甲醇 苯并[D]恶唑-7-胺 苯并[D]噁唑-4-基氨基甲酸叔丁酯 苯并[D]噁唑-2-羧酸钾 苯并-13C6-噁唑 离子载体 碘化二氢2-[3-(5,6-二氯-1,3-二乙基-1,3--2H-苯并咪唑-2-亚基)丙-1-烯基]-3-乙基-5-苯基苯并噁唑正离子 硫代偏糖醛 甲酰胺,N-乙基-N-[6-[(3-甲酰基苯氧基)甲基]-2-苯并噁唑基]- 甲酰胺,N-[6-(溴甲基)-2-苯并噁唑基]-N-乙基- 甲基硫酸1-甲基-8-[(甲基氨基甲酰)氧代]喹啉正离子 甲基6-氨基-1,3-苯并恶唑-2-羧酸酯 甲基2-氨基-1,3-苯并恶唑-5-羧酸酯 甲基1,3-苯并恶唑-2-基乙酸酯 甲基-2-乙基-1,3-苯并唑-5-羧酸乙酯 甲基-1,3-苯并唑-5-羧酸乙酯 环戊二烯并[e][1,3]恶嗪-5,6-二胺 环戊二烯并[d][1,3]恶嗪-6,7-二胺 溴氯唑酮 溴化二氢2-[3-[1-[4-[(乙酰氨基)磺基基]丁基]-5,6-二氯-3-乙基-1,3--2H-苯并咪唑-2-亚基]丙-1-烯基]-3-乙基-5-苯基苯并噁唑正离子 氰基二硫代亚氨酸(6-氯-2-氧代-3(2H)-苯并恶唑基)甲基甲基酯 氰基-二硫代亚氨酸甲基(2-氧代-3(2H)-苯并恶唑基)甲基酯 氯唑沙宗-2-13C-3-15N-羟基-18O 氯唑沙宗 氯化3-乙基-2-[2-(1-乙基-2,5-二甲基-1H-吡咯-3-基)乙烯基]苯并恶唑翁盐 昂唑司特 拂来星-d2